Sunscreen and Minoxidil Studies Presented at EADV Congress
New data details how specific skincare and hair treatments performed in clinical studies involving skin health and hair regrowth.
Updated on Sept. 30, 2026 in Nutrition
Live Poll
Do you look for science-backed clinical evidence before purchasing new skincare or hair products?
At the 35th European Academy of Dermatology and Venereology Congress in Vienna, Neutrogena, Aveeno, and Regaine presented 12 scientific data sets. The findings offer new insights into treatments for conditions ranging from acne and hyperpigmentation to androgenetic alopecia.
Why it matters
This research aims to clarify how science-backed ingredients influence outcomes for common dermatological concerns. Understanding these results can help patients and clinicians make more informed decisions regarding skincare routines and hair loss management.
A multi-ethnic clinical study of acne-prone skin found a 56% reduction in redness and 46% decrease in hyperpigmentation after 28 days of sunscreen use. Additionally, a survey of 178 clinicians reported that 92.7% observed steroid-sparing effects when using colloidal oat-based emollients.
The players
Neutrogena
A brand specializing in dermatological skincare products and sun protection.
Aveeno
A manufacturer focused on skincare products utilizing natural ingredients like colloidal oat.
Regaine
A pharmaceutical brand known for producing minoxidil-based treatments for hair regrowth.
The details
The studied sunscreen, containing 2% trehalose and 2% niacinamide, targets skin surface barrier properties to potentially mitigate inflammation and oil production. For hair loss, the 5% Minoxidil Topical Foam acts by extending the anagen, or growth, phase of hair follicles in men experiencing androgenetic alopecia, which affects up to 50% of men by age 50.
Timeline
September 30, 2026: The 35th EADV Congress begins in Vienna.
October 3, 2026: The 35th EADV Congress concludes.
Health Landscape
These presentations reflect the ongoing effort to modernize dermatological care through ingredient-specific clinical validation. They align with the broader medical trend of refining treatments for androgenetic alopecia and inflammatory skin conditions like acne.
If you are managing acne or hair thinning, these findings highlight the potential benefit of targeted ingredients like niacinamide or minoxidil. Discussing these study outcomes with your dermatologist can help determine if such interventions are appropriate for your specific skin or hair goals.
The takeaway
Science-backed ingredients can offer measurable improvements in skin appearance and hair density. Tracking your own progress over 16 to 28 weeks can help you determine the efficacy of a treatment in consultation with your physician.
Further reading
For more information on the latest research in dermatological health, visit the Nutrition section.
Live Poll
Do you look for science-backed clinical evidence before purchasing new skincare or hair products?
